Eris Lifesciences Limited

NSE:ERIS.NS

1389.45 (INR) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012
Assets:
Current Assets:
Cash & Cash Equivalents 14,006.3560.22507.94368.7672.1175106.0824.2188.6857.2172.8548.97
Short Term Investments 0.02332.211,264.47153.99747.813,149.42937.892,584.83653.2692.4669.64465
Cash and Short Term Investments 14,006.32892.431,772.41522.691,419.923,224.421,043.972,609.04741.88749.61742.49513.97
Net Receivables 4,275.832,966.952,260.932,280.612,076.451,760.371,287.51603.99373.39236.66223.4165.96
Inventory 1,890.321,314.351,179.11944.66694.75826.53654.48558.2476.21576.05448.11431.98
Other Current Assets 2,848.262,473.491,060.85922.52,681.56.471.1173.541.42309.12364.18317.6
Total Current Assets 23,020.737,647.226,273.34,670.464,796.175,817.792,987.073,844.771,592.91,634.781,554.781,263.55
Non-Current Assets:
Property, Plant & Equipment, Net 5,236.533,773.791,918.57778.78872.43560.71526.12553.86706.66674.99710.51235.17
Goodwill 8,612.133,318.49934.74934.74934.74935.871,869.48792.61035.5332.1632.84
Intangible Assets 29,623.2518,805.966,595.986,840.766,984.696,136.086,250.07363.346.956.96.580.82
Goodwill and Intangible Assets 38,235.3822,124.457,530.727,775.57,919.437,071.958,119.551,155.956.9542.4338.7433.66
Long Term Investments 259.1468.774,208.442,859.1532.04409.121,778.21-2,483.86890.34280.37-499.62-464.93
Tax Assets 3,069.412,739.452,431.342,006.321,709.111,447.941,005.6795.15186.9233.092.142.62
Other Non-Current Assets 667.18319.6359.02257.59193.87229.11184.233,244.1802.01907.19899.44647.98
Total Non-Current Assets 47,467.6429,026.0616,448.0913,677.3410,726.889,718.8311,613.782,565.22,592.881,938.071,151.21454.5
Total Assets 70,488.3736,673.2822,721.3918,347.815,523.0515,536.6214,600.856,409.974,185.783,572.852,705.991,718.05
Liabilities & Equity:
Current Liabilities:
Account Payables 2,683.481,247.691,177.741,026.161,000.51841.25911.03385.17277.7367.11373.83220.17
Short Term Debt 20,897.431,932.940.1323.359.991,761.31,026.0472.65528.5679.3662.2
Tax Payables 395.93969.9777.5169.9818.1125.5722.85170.48000
Deferred Revenue 395.91,034.52626.22487.39424.32271.4120.97241.763.42222.83222128.74
Other Current Liabilities 1,343.96217.22152.37132.46162.08181.41296.5658.61403.3940.2141.2724.45
Total Current Liabilities 25,320.774,432.331,996.461,669.311,646.93,055.372,254.6758.19689.51658.71716.46435.56
Non-Current Liabilities:
Long Term Debt 6,545.076,834.21803.9444.4761.442.932,741.954.940505.63
Deferred Revenue Non-Current 370.1987.3956.8861.1185.4566.63209.7210.7805.632.990.81
Deferred Tax Liabilities Non-Current 5,428.182,576.38460.94495.38506.15516.95522.7211.530199.870152.33
Other Non-Current Liabilities 603.85536.2321.14313.3259.77206.4712.1625.29255.837.74177.9515.39
Total Non-Current Liabilities 12,947.2910,034.181,642.9914.26912.81792.983,486.53252.54255.83218.24180.94174.16
Total Liabilities 38,268.0614,466.513,639.362,583.572,559.713,848.355,741.131,010.73945.34876.95897.4609.72
Equity:
Preferred Stock 021,930.1219,062.4115,722.7313,590.8512,056.17000000
Common Stock 136.03135.99135.93135.78135.78137.5137.5137.51.381.381.381.38
Retained Earnings 25,492.5721,559.318,736.5315,503.1312,797.2811,335.228,468.575,254.743,200.042,648.281,756.661,052.47
Accumulated Other Comprehensive Income/Loss 25,725.1629.7620.741.48-711.33-543.99-389.87-619.967-315.35-163.28-118.04
Other Total Stockholders Equity -25,492.57-21,695.29-18,872.46-15,638.91-12,849.24-11,479.74396.87626.960322.35170.28125.04
Total Shareholders Equity 25,861.1921,959.8819,083.1115,764.2112,963.3411,505.168,613.075,399.243,208.422,656.661,765.041,060.85
Total Equity 32,220.3122,206.7719,082.0315,764.2312,963.3411,688.278,859.725,637.173,240.442,695.91,808.591,108.33
Total Liabilities & Shareholders Equity 70,488.3736,673.2822,721.3918,347.815,523.0515,536.6214,600.856,409.974,185.783,572.852,705.991,718.05